# 510(K) SUMMARY

This summary of $5 1 0 ( \mathbf { k } )$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR $\$ 807.92$ .

The assiged 510(k) numbers: Ko72018

# Submitter:

Shenzhen Mindray Bio-medical Electronics Co., LTD Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China

Tel: +86 755 2658 2888   
Fax: +86 755 2658 2680

Contact Person:

Li Dongling   
Shenzhen Mindray Bio-medical Electronics Co., LTD   
Mindray Building, Keji 12th Road South, Hi-tech Industrial Park,   
Nanshan, Shenzhen, 518057, P. R. China

Date Prepared:

Mar. 5, 2007

# Name of the device:

Trade/Proprietary Name: BS-200 Chemistry Analyzer

Common Name: Clinical Chemistry Analyzer (with optional ISE Module)

Classification Number/Class:

75JJE, Class I   
75CRF, Class II   
75CEM, Class II   
75CGE, Class II   
75JGS, Class II

# Legally Marketed Predicate Device:

K953239 Boehringer Mannheim/Hitachi 917 Analyzer K000926 EasyElectroLyte/RapidLyte Na/K/Cl Analyzer K002199 Liquid Glucose (Hexokinase) Reagent Set

# Description:

The BS-200 Chemistry Analyzer is an automated clinical chemistry analyzer capable of performing various in vitro photometric assays. The Glucose was cleared under K002199 and is the chosen assay to demonstrate performance for the photometric unit. The BS-200 Chemistry Analyzer has an optional Ion-Selective Electrode (ISE) module which measures the concentration of the electrolytes, sodium, potassium, and chloride, in samples using ion selective electrode technology.

# Intended Use:

The BS-200 Chemistry Analyzer is an automated chemistry analyzer for in vitro diagnostic use in cnical laboratoris.Theanalyze is designe or thenviro quantitativedeterinatin o cal chemistries in serum, plasma, urine or cerebral spinal fluid samples.

# Indications for Use:

The BS-200 Chemistry Analyzer is designed for clinical laboratory use, making direct quantitative measurements of $\mathbf { N a } +$ (sodium), $\mathsf { K } +$ (potassium), Cl-(chloride) in serum, plasma and urine samples and Glucose in serum samples. Additionally, other various chemistry assays may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.

Sodium measurements are used in the diagnosis and treatment diseases involving electrolyte imbalance.

Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathichypoglycemia, and of pancreatic islet cell carcinoma.

# Comparison of Technological Characteristics:

Substantial equivalence has been demonstrated between the BS-200 Chemistry Analyzer and Boehringer Mannheim/Hitachi 917 analyzer. Both of them utilize absorbance photometry to perform and output quantitative results for kinetic and endpoint clinical chemistries. For analytes, the BS-200 Chemistry Analyzer and Boehringer Mannheim/Hitachi 917 analyzer determine the concentration of unknown samples from a standard curve generated with known analyte concentrations. Substantial equivalence has also been demonstrated between the BS-200 Chemistry Analyzer and EasyElectroLyte/RapidLyte $\mathrm { N a / K / C l }$ Analyzer. Both of them are used to analyze for electrolytes. The analyzers are calibrated with known concentration calibrator material. The BS-200 Chemistry Analyzer and EasyElectroLyte/RapidLyte $\mathrm { N a } / \mathrm { K } / \mathrm { C l }$ Analyzer both utilize Ion-Selective Electrodes technology.

# Performance Characteristics:

Performance testing of the BS-200 Chemistry Analyzer consisted of running the FDA previously cleared assay and the ISE module on the BS-200 to evaluate precision, linearity, and method comparison, Limits of Detection and Limits of Quantitation, interference.

A correlation analysis between the BS-200 Chemistry Analyzer and the predicate devices yielded the following results:   

<table><tr><td rowspan=1 colspan=1>ltem</td><td rowspan=1 colspan=1>RegressionSlope</td><td rowspan=1 colspan=1>RegressionIntercept</td><td rowspan=1 colspan=1>CorrelationCoefficient(r)</td><td rowspan=1 colspan=1>Samplenumbers</td></tr><tr><td rowspan=1 colspan=1>GLU(mg/dL)</td><td rowspan=1 colspan=1>1.015</td><td rowspan=1 colspan=1>-0.0288</td><td rowspan=1 colspan=1>0.9992</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>0.9864</td><td rowspan=1 colspan=1>0.1226</td><td rowspan=1 colspan=1>0.9980</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>0.9903</td><td rowspan=1 colspan=1>1.3158</td><td rowspan=1 colspan=1>0.9845</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>0.9815</td><td rowspan=1 colspan=1>3.4021</td><td rowspan=1 colspan=1>0.9905</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>0.9668</td><td rowspan=1 colspan=1>0.5307</td><td rowspan=1 colspan=1>0.9991</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L) Urine(ISE)</td><td rowspan=1 colspan=1>0.9479</td><td rowspan=1 colspan=1>-3.1284</td><td rowspan=1 colspan=1>0.9977</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>1.001</td><td rowspan=1 colspan=1>-6.9595</td><td rowspan=1 colspan=1>0.9887</td><td rowspan=1 colspan=1>40</td></tr></table>

The Within-Run precision test yielded the following results: Glucose

<table><tr><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td><td rowspan=1 colspan=3>Level III</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td></tr><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td></tr><tr><td rowspan=1 colspan=1>55.9</td><td rowspan=1 colspan=1>0.51</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>121.5</td><td rowspan=1 colspan=1>0.73</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>295.63</td><td rowspan=1 colspan=1>1.33</td><td rowspan=1 colspan=1>0.5%</td></tr></table>

ISE Chemistries   
Page 3 of 5   

<table><tr><td colspan="1" rowspan="2">Item</td><td colspan="3" rowspan="1">Level I</td><td colspan="3" rowspan="1">Level II</td></tr><tr><td colspan="1" rowspan="1">Mean</td><td colspan="1" rowspan="1">SD</td><td colspan="1" rowspan="1">CV%</td><td colspan="1" rowspan="1">Mean</td><td colspan="1" rowspan="1">SD</td><td colspan="1" rowspan="1">CV%</td></tr><tr><td colspan="1" rowspan="1">K serum(ISE)</td><td colspan="1" rowspan="1">4.11</td><td colspan="1" rowspan="1">0.03</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">6.77</td><td colspan="1" rowspan="1">0.05</td><td colspan="1" rowspan="1">0.8%</td></tr><tr><td colspan="1" rowspan="1">Na serum(ISE)</td><td colspan="1" rowspan="1">136.13</td><td colspan="1" rowspan="1">0.61</td><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">146.74</td><td colspan="1" rowspan="1">0.72</td><td colspan="1" rowspan="1">0.5%</td></tr><tr><td colspan="1" rowspan="1">CL serum(ISE)</td><td colspan="1" rowspan="1">99.59</td><td colspan="1" rowspan="1">0.73</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">115.68</td><td colspan="1" rowspan="1">0.52</td><td colspan="1" rowspan="1">0.5%</td></tr><tr><td colspan="1" rowspan="1">K Urine(ISE)</td><td colspan="1" rowspan="1">37.09</td><td colspan="1" rowspan="1">0.46</td><td colspan="1" rowspan="1">1.2%</td><td colspan="1" rowspan="1">67.49</td><td colspan="1" rowspan="1">0.63</td><td colspan="1" rowspan="1">0.9%</td></tr><tr><td colspan="1" rowspan="1">Na Urine(ISE)</td><td colspan="1" rowspan="1">99.23</td><td colspan="1" rowspan="1">1.13</td><td colspan="1" rowspan="1">1.1%</td><td colspan="1" rowspan="1">170.84</td><td colspan="1" rowspan="1">1.36</td><td colspan="1" rowspan="1">0.8%</td></tr><tr><td colspan="1" rowspan="1">CL Urine(ISE)</td><td colspan="1" rowspan="1">82.90</td><td colspan="1" rowspan="1">1.36</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">132.16</td><td colspan="1" rowspan="1">1.24</td><td colspan="1" rowspan="1">0.9%</td></tr></table>

The Between-run imprecision test yielded the following results: Glucose

<table><tr><td rowspan=1 colspan=3>Level I</td><td rowspan=1 colspan=3>Level II</td><td rowspan=1 colspan=3>Level III</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV</td></tr><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>%</td></tr><tr><td rowspan=1 colspan=1>55.9</td><td rowspan=1 colspan=1>1.51</td><td rowspan=1 colspan=1>2.7%</td><td rowspan=1 colspan=1>121.5</td><td rowspan=1 colspan=1>2.46</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>295.63</td><td rowspan=1 colspan=1>5.28</td><td rowspan=1 colspan=1>1.8%</td></tr></table>

ISE Chemistries   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Level l</td><td rowspan=1 colspan=3>Level II</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L)serum(ISE)</td><td rowspan=1 colspan=1>4.11</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>6.77</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>1.0%</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L)serum(ISE)</td><td rowspan=1 colspan=1>136.13</td><td rowspan=1 colspan=1>2.12</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>146.74</td><td rowspan=1 colspan=1>1.66</td><td rowspan=1 colspan=1>1.1%</td></tr><tr><td rowspan=1 colspan=1>CL(mmol/L)serum(ISE)</td><td rowspan=1 colspan=1>99.59</td><td rowspan=1 colspan=1>1.78</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>115.68</td><td rowspan=1 colspan=1>1.13</td><td rowspan=1 colspan=1>1.0%</td></tr><tr><td rowspan=1 colspan=1>Kmmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>37.09</td><td rowspan=1 colspan=1>0.48</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>67.49</td><td rowspan=1 colspan=1>0.70</td><td rowspan=1 colspan=1>1.0%</td></tr><tr><td rowspan=1 colspan=1>Nammol/L)Urine(ISE)</td><td rowspan=1 colspan=1>99.23</td><td rowspan=1 colspan=1>1.68</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>170.84</td><td rowspan=1 colspan=1>2.41</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>82.90</td><td rowspan=1 colspan=1>1.50</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>132.16</td><td rowspan=1 colspan=1>2.12</td><td rowspan=1 colspan=1>1.6%</td></tr></table>

The linearity test yielded the following results:   
Page 4 of 5   

<table><tr><td colspan="1" rowspan="2">Item</td><td colspan="2" rowspan="1">Linear range</td></tr><tr><td colspan="1" rowspan="1">Lower limit</td><td colspan="1" rowspan="1">Upper limit</td></tr><tr><td colspan="1" rowspan="1">GLU (mg/dL)</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">686</td></tr><tr><td colspan="1" rowspan="1">K (mmol/L) serum(ISE)</td><td colspan="1" rowspan="1">1.1</td><td colspan="1" rowspan="1">8.6</td></tr><tr><td colspan="1" rowspan="1">Na (mmol/L) serum(ISE)</td><td colspan="1" rowspan="1">113</td><td colspan="1" rowspan="1">194</td></tr><tr><td colspan="1" rowspan="1">CL (mmol/L) serum(ISE)</td><td colspan="1" rowspan="1">53</td><td colspan="1" rowspan="1">154</td></tr><tr><td colspan="1" rowspan="1">K (mmol/L)Urine(ISE)</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">184</td></tr><tr><td colspan="1" rowspan="1">Na (mmol/L) Urine(ISE)</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">372</td></tr><tr><td colspan="1" rowspan="1">CL (mmol/L)Urine(ISE)</td><td colspan="1" rowspan="1">42</td><td colspan="1" rowspan="1">422</td></tr></table>

The Limit of Detection test yielded the following results:   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>LoB</td><td rowspan=1 colspan=1>LoD</td><td rowspan=1 colspan=1>LoQ</td></tr><tr><td rowspan=1 colspan=1>GLU(mg/dl)</td><td rowspan=1 colspan=1>0.04</td><td rowspan=1 colspan=1>0.22</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>0.16</td><td rowspan=1 colspan=1>0.42</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>1.15</td><td rowspan=1 colspan=1>2.67</td><td rowspan=1 colspan=1>5.3</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>2.95</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>12.0</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>0.26</td><td rowspan=1 colspan=1>0.58</td><td rowspan=1 colspan=1>1.34</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L) Urine(ISE)</td><td rowspan=1 colspan=1>5.85</td><td rowspan=1 colspan=1>8.27</td><td rowspan=1 colspan=1>22.2</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L)Urine(ISE)</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>6.29</td><td rowspan=1 colspan=1>17.1</td></tr></table>

The Interference test yielded the following results:   

<table><tr><td rowspan=2 colspan=1>Item</td><td rowspan=1 colspan=3>Interference materials</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Intralipids</td></tr><tr><td rowspan=1 colspan=1>GLU (mg/dl</td><td rowspan=1 colspan=1>250mg/dl</td><td rowspan=1 colspan=1>18 mg/dl</td><td rowspan=1 colspan=1>300mg/dl</td></tr><tr><td rowspan=1 colspan=1>K (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>&gt;500mg/dl</td><td rowspan=1 colspan=1>&gt;20mg/dl</td><td rowspan=1 colspan=1>&gt;1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>Na (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>&gt;500mg/dl</td><td rowspan=1 colspan=1>&gt;20mg/dl</td><td rowspan=1 colspan=1>&gt;1000 mg/dl</td></tr><tr><td rowspan=1 colspan=1>CL (mmol/L) serum(ISE)</td><td rowspan=1 colspan=1>&gt;500mg/dl</td><td rowspan=1 colspan=1>&gt;20mg/dl</td><td rowspan=1 colspan=1>&gt;1000 mg/dl</td></tr></table>

# Conclusion:

The data demonstrates that the BS-200 Chemistry Analyzer is substantially equivalent to Boehringer Mannheim/Hitachi 917 Analyzer and EasyElectroLyte/RapidLyte $\mathrm { { N a } / \mathrm { { K } / \mathrm { { C l } } } }$ Analyzer.

# FEB - 1 2008

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. c/o Susan D. Goldstein-Falk   
mdi Consultants, Inc.   
55 Northern Blvd., Suite 200   
Great Neck, NY 11021 US

Re: k072018 Trade/Device Name: BS-200 Chemistry Analyzer Regulation Number: 21 CFR 862.1345 Regulation Name: Glucose Test System Regulatory Class: Class II Product Code: CFR, JGS, CEM, CGZ, JJE Dated: January 25, 2008 Received: January 28, 2008

Dear Ms. Goldstein Falk:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in acordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Tie 1, Code of Federal Regulations (CFR), Parts 800 to 895. In adition, FDA my publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a leally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0490. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address at   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Jean M.Coopes, M.S. D.V.M. Jean M. Cooper, M.S., D.V.M.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

Enclosure

# Indication for Use

510(k) Number (if known): K07.2018

DoviceName: Nat, K, C1, glucox tests on the BS-2oo Analyzer

Indication For Use:

The BS-200 Chemistry Analyzer is designed for clinical laboratory use, making direct quantitative measurements of Na+ (sodium), K+ (potassium), Cl-(chloride) in serum, plasma and urine samples and Glucose in serum samples. Additionally, other various chemistry assays may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.

Sodium measurements are used in the diagnosis and treatment diseases involving electrolyte imbalance.

Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

Prescription Use _X (21 CFR Part 801 Subpart D)

And/Or

Over the Counter Use. (21 CFR Part 801 Subpart C)

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/63a02b1bbb27791211ed1cc1c7ddda03b1457268138b6d4f3135214fd12caf3a.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) k072018